Medicamen Biotech Limited (BOM:531146)
India · Delayed Price · Currency is INR 221.85
-18.90 (-7.85%)
At close: Aug 17, 2026
Medicamen Biotech Employees
Medicamen Biotech had 376 employees as of March 31, 2025. The number of employees decreased by 2 or -0.53% compared to the previous year.
Employees
376
Change (1Y)
-2
Growth (1Y)
-0.53%
Revenue / Employee
5.48M INR
Profits / Employee
255.50K INR
Market Cap
2.82B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 376 | -2 | -0.53% |
| Mar 31, 2024 | 378 | -10 | -2.58% |
| Mar 31, 2023 | 388 | 31 | 8.68% |
| Mar 31, 2022 | 357 | 68 | 23.53% |
| Mar 31, 2021 | 289 | 25 | 9.47% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Everest Organics | 355 |
| Medico Remedies | 213 |
| Coral Laboratories | 197 |
| Oxygenta Pharmaceutical | 170 |
| Gennex Laboratories | 115 |
| BDH Industries | 95 |
| Bilcare | 78 |
| Trident Lifeline | 74 |
Medicamen Biotech News
- 1 year ago - Medicamen Biotech secures USFDA nod for Bortezomib injection, marks its first ANDA approval - Business Upturn
- 1 year ago - Medicamen Biotech shares surge 8% after signing contract for CDMO with XGX pharma - Business Upturn
- 1 year ago - Medicamen Biotech expands into South Africa after EU approval, eyes $4 billion pharmaceutical market - Business Upturn
- 1 year ago - Medicamen Biotech shares jump 3.50% after signing long-term manufacturing deal for US and Europe - Business Upturn
- 1 year ago - Medicamen Biotech secures 10-year manufacturing and supply deal with leading US pharma distributor - Business Upturn
- 1 year ago - Medicamen Biotech shares surge nearly 15% - Business Upturn